Acutus Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Acutus Medical, dedicated to arrhythmia management, announced its management's participation in the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020. The company focuses on enhancing cardiac arrhythmia diagnosis and treatment through innovative electrophysiology technologies. Established in 2011 and based in Carlsbad, California, Acutus aims to provide comprehensive catheter-based solutions for arrhythmia treatment globally.
- None.
- None.
CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced that its management will participate at the upcoming Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.
About Acutus Medical, Inc.
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions, and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products. Acutus Medical’s goal is to provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias in each of its geographic markets. Founded in 2011, Acutus is based in Carlsbad, California.
Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-314-1725
Caroline.corner@westwicke.com
Holly Windler
M: 619-929-1275
media@acutusmedical.com
FAQ
What event will Acutus Medical participate in November 2020?
What is Acutus Medical's focus in the healthcare sector?
When was Acutus Medical founded?
What is Acutus Medical's stock symbol?
Where is Acutus Medical based?
